Volver a Agenda
Session Chair(s)
Representative Invited
University Freiburg Inst. F.Pharmaceutical Sciences, Germany
Speaker(s)
CRO’s Perspective on Feasibility and Challenges with Paediatric Clinical Trials
Martine Dehlinger-Kremer, PHD
UCB Biosciences, Germany
Sn Drug Development Strategy Lead Pediatrics
HCP Voice on Practical Challenges/Suggestions
Mark Turner, MD, PHD, MRCP, FFPM
University of Liverpool, United Kingdom
Chief Executive Officer of the c4c- Stichting (c4c-S) & Professor of Neonatology
The Case for a Global Pediatric Clinical Trials Network; and Progress Towards that Goal
William R. Treem
Janssen Pharmaceutical Research and Development, United States
Senior Director, Pediatric Drug Development
¿Tiene una cuenta?